Connection

Perry Halushka to Receptors, Thromboxane

This is a "connection" page, showing publications Perry Halushka has written about Receptors, Thromboxane.
Connection Strength

5.000
  1. Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring. Prostaglandins Other Lipid Mediat. 2011 Nov; 96(1-4):41-4.
    View in: PubMed
    Score: 0.400
  2. Thromboxane A(2) receptors: where have you gone? Prostaglandins Other Lipid Mediat. 2000 Mar; 60(4-6):175-89.
    View in: PubMed
    Score: 0.179
  3. Coupling of thromboxane A2 receptor isoforms to Galpha13: effects on ligand binding and signalling. Biochim Biophys Acta. 1999 Jul 08; 1450(3):288-96.
    View in: PubMed
    Score: 0.171
  4. Expression, characterization, and purification of C-terminally hexahistidine-tagged thromboxane A2 receptors. J Biol Chem. 1998 Aug 28; 273(35):22753-60.
    View in: PubMed
    Score: 0.161
  5. Cloning and characterization of an endogenous COS-7 cell thromboxane A2 receptor. Biochim Biophys Acta. 1998 May 27; 1403(1):109-14.
    View in: PubMed
    Score: 0.159
  6. Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smooth-muscle cells. J Cardiovasc Pharmacol. 1997 Mar; 29(3):311-5.
    View in: PubMed
    Score: 0.146
  7. Thromboxane A2 receptor density increases during chronic exposure to thromboxane A2 receptor antagonists after porcine carotid bypass. Cardiovasc Surg. 1997 Feb; 5(1):92-8.
    View in: PubMed
    Score: 0.145
  8. Modification on ligand binding to TXA2/PGH2 receptors by diethylpyrocarbonate. Adv Exp Med Biol. 1997; 400A:235-40.
    View in: PubMed
    Score: 0.144
  9. Inhibition of testosterone 5 alpha-reductase: evidence for tissue-specific regulation of thromboxane A2 receptors. J Pharmacol Exp Ther. 1996 Dec; 279(3):1386-91.
    View in: PubMed
    Score: 0.143
  10. Characterization of the cloned HEL cell thromboxane A2 receptor: evidence that the affinity state can be altered by G alpha 13 and G alpha q. J Pharmacol Exp Ther. 1996 May; 277(2):1132-9.
    View in: PubMed
    Score: 0.137
  11. Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells. Life Sci. 1996; 58(8):683-90.
    View in: PubMed
    Score: 0.134
  12. Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclase. Am J Physiol. 1996 Jan; 270(1 Pt 2):F31-8.
    View in: PubMed
    Score: 0.134
  13. Thromboxane A2 receptors. J Lipid Mediat Cell Signal. 1995 Oct; 12(2-3):361-78.
    View in: PubMed
    Score: 0.132
  14. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995 Jun 01; 91(11):2742-7.
    View in: PubMed
    Score: 0.129
  15. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine. Biochem Pharmacol. 1995 Mar 30; 49(7):921-7.
    View in: PubMed
    Score: 0.127
  16. Sex steroid regulation of thromboxane A2 receptors in cultured rat aortic smooth muscle cells. Prostaglandins. 1995 Mar; 49(3):183-96.
    View in: PubMed
    Score: 0.127
  17. Testosterone regulation of platelet and vascular thromboxane A2 receptors. Agents Actions Suppl. 1995; 45:19-26.
    View in: PubMed
    Score: 0.125
  18. Androgen regulation of thromboxane A2 receptors. Adv Prostaglandin Thromboxane Leukot Res. 1995; 23:251-3.
    View in: PubMed
    Score: 0.125
  19. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol. 1994 Sep; 267(3 Pt 2):H887-93.
    View in: PubMed
    Score: 0.122
  20. Characterization of human peripheral blood monocyte thromboxane A2 receptors. J Pharmacol Exp Ther. 1994 Aug; 270(2):446-52.
    View in: PubMed
    Score: 0.122
  21. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors. Biochim Biophys Acta. 1994 Mar 10; 1221(1):83-8.
    View in: PubMed
    Score: 0.118
  22. The Gordon Wilson Lecture. Regulation of thromboxane A2 receptors by testosterone: implications for steroid abuse and cardiovascular disease. Trans Am Clin Climatol Assoc. 1994; 105:95-103.
    View in: PubMed
    Score: 0.117
  23. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells. Am J Physiol. 1993 Dec; 265(6 Pt 1):E928-34.
    View in: PubMed
    Score: 0.116
  24. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat. Prostaglandins. 1993 May; 45(5):427-38.
    View in: PubMed
    Score: 0.112
  25. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension. Thromb Res. 1993 May 01; 70(3):205-10.
    View in: PubMed
    Score: 0.112
  26. Thromboxane A2 receptors in equine monocytes: identification of a new subclass of TXA2 receptors. J Leukoc Biol. 1993 Feb; 53(2):173-8.
    View in: PubMed
    Score: 0.110
  27. Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis. Cancer Res. 2008 Jun 01; 68(11):4097-104.
    View in: PubMed
    Score: 0.079
  28. The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cells. J Pharmacol Exp Ther. 2003 Dec; 307(3):1142-7.
    View in: PubMed
    Score: 0.058
  29. Progesterone regulation of vascular thromboxane A(2) receptors in rhesus monkeys. Am J Physiol Heart Circ Physiol. 2001 Oct; 281(4):H1498-507.
    View in: PubMed
    Score: 0.050
  30. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1998 Apr 28; 95(9):4888-93.
    View in: PubMed
    Score: 0.039
  31. Activation of thromboxane A2 receptors alters lipopolysaccharide-induced adherence of THP-1 cells. Shock. 1996 Jan; 5(1):41-6.
    View in: PubMed
    Score: 0.034
  32. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther. 1994 Sep; 270(3):1192-6.
    View in: PubMed
    Score: 0.031
  33. Decrease in vascular TxA2 receptors in a subgroup of rabbits unresponsive to a TxA2 mimetic. Am J Physiol. 1994 Jun; 266(6 Pt 2):H2320-6.
    View in: PubMed
    Score: 0.030
  34. Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest. 1994 Feb; 24 Suppl 1:50-2.
    View in: PubMed
    Score: 0.029
  35. Thromboxane A2 receptor blockade improves renal function and histopathology in the post-obstructive kidney. Kidney Int. 1994 Jan; 45(1):185-92.
    View in: PubMed
    Score: 0.029
  36. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets. Eur J Pharmacol. 1992 Sep 01; 227(1):71-8.
    View in: PubMed
    Score: 0.027
  37. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Aug; 262(2):632-7.
    View in: PubMed
    Score: 0.027
  38. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1992 Jul; 262(1):238-45.
    View in: PubMed
    Score: 0.026
  39. Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells. Circ Res. 1991 Sep; 69(3):638-43.
    View in: PubMed
    Score: 0.025
  40. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets. J Biol Chem. 1991 Jul 25; 266(21):13752-8.
    View in: PubMed
    Score: 0.025
  41. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Biochem Pharmacol. 1991 Jul 15; 42(3):537-44.
    View in: PubMed
    Score: 0.025
  42. Novel synthesis and biochemical properties of an [125I]-labeled photoaffinity probe for thromboxane A2/prostaglandin H2 receptors. J Med Chem. 1991 Apr; 34(4):1511-4.
    View in: PubMed
    Score: 0.024
  43. Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor. Eur J Pharmacol. 1991 Jan 25; 206(1):15-21.
    View in: PubMed
    Score: 0.024
  44. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Adv Prostaglandin Thromboxane Leukot Res. 1991; 21A:331-7.
    View in: PubMed
    Score: 0.024
  45. Thromboxane A2 receptors are influenced by cell density in cultured rat aortic smooth muscle cells. Life Sci. 1991; 48(25):2391-5.
    View in: PubMed
    Score: 0.024
  46. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors. Biochem Pharmacol. 1990 Oct 01; 40(7):1457-61.
    View in: PubMed
    Score: 0.023
  47. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction. Circulation. 1990 Jan; 81(1):212-8.
    View in: PubMed
    Score: 0.022
  48. Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells. Life Sci. 1990; 46(24):1765-72.
    View in: PubMed
    Score: 0.022
  49. I-BOP, the most potent radiolabelled agonist for the TXA2/PGH2 receptor. Adv Prostaglandin Thromboxane Leukot Res. 1990; 20:102-9.
    View in: PubMed
    Score: 0.022
  50. Radioligand binding assays for thromboxane A2/prostaglandin H2 receptors. Methods Enzymol. 1990; 187:397-405.
    View in: PubMed
    Score: 0.022
  51. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J Pharmacol Exp Ther. 1989 Nov; 251(2):557-62.
    View in: PubMed
    Score: 0.022
  52. Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors. J Pharmacol Exp Ther. 1989 Sep; 250(3):923-7.
    View in: PubMed
    Score: 0.022
  53. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor. Biochim Biophys Acta. 1989 Jul 11; 1012(2):184-90.
    View in: PubMed
    Score: 0.021
  54. Photoaffinity labelling and isoelectric focusing of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Adv Prostaglandin Thromboxane Leukot Res. 1989; 19:168-71.
    View in: PubMed
    Score: 0.021
  55. Thromboxane and prostacyclin receptors. Prog Clin Biol Res. 1989; 301:21-8.
    View in: PubMed
    Score: 0.021
  56. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor. Prog Clin Biol Res. 1989; 301:303-7.
    View in: PubMed
    Score: 0.021
  57. Pharmacology of thromboxane A2 receptor antagonists. Z Kardiol. 1989; 78 Suppl 3:42-7.
    View in: PubMed
    Score: 0.021
  58. Thromboxane, prostaglandin and leukotriene receptors. Annu Rev Pharmacol Toxicol. 1989; 29:213-39.
    View in: PubMed
    Score: 0.021
  59. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Biochem Biophys Res Commun. 1988 Dec 15; 157(2):733-9.
    View in: PubMed
    Score: 0.021
  60. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619. J Pharmacol Exp Ther. 1988 Dec; 247(3):1133-8.
    View in: PubMed
    Score: 0.021
  61. Different pharmacologic activities for 13-azapinane thromboxane A2 analogs in platelets and blood vessels. Eur J Pharmacol. 1988 Apr 13; 148(3):309-15.
    View in: PubMed
    Score: 0.020
  62. Subcellular localization of a thromboxane A2/prostaglandin H2 receptor antagonist binding site in human platelets. Biochem Pharmacol. 1988 Feb 15; 37(4):647-54.
    View in: PubMed
    Score: 0.019
  63. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant. Biochem Pharmacol. 1987 Jun 15; 36(12):1913-7.
    View in: PubMed
    Score: 0.019
  64. Cultured human vascular smooth muscle cells with functional thromboxane A2 receptors: measurement of U46619-induced 45calcium efflux. Circ Res. 1987 Jun; 60(6):952-6.
    View in: PubMed
    Score: 0.019
  65. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets. Prostaglandins. 1987 Jun; 33(6):789-97.
    View in: PubMed
    Score: 0.019
  66. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors. Fed Proc. 1987 Jan; 46(1):149-53.
    View in: PubMed
    Score: 0.018
  67. Photoaffinity labelling of a thromboxane A2/prostaglandin H2 antagonist binding site in human platelets. Biochem Biophys Res Commun. 1986 Oct 15; 140(1):128-33.
    View in: PubMed
    Score: 0.018
  68. Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes. J Biol Chem. 1986 Mar 05; 261(7):3025-9.
    View in: PubMed
    Score: 0.017
  69. Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer. Cancer Res. 2005 Dec 15; 65(24):11581-7.
    View in: PubMed
    Score: 0.017
  70. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle. Circulation. 1985 Dec; 72(6):1202-7.
    View in: PubMed
    Score: 0.017
  71. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. J Pharmacol Exp Ther. 1985 Dec; 235(3):729-34.
    View in: PubMed
    Score: 0.017
  72. Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Proc Natl Acad Sci U S A. 1985 Nov; 82(21):7434-8.
    View in: PubMed
    Score: 0.017
  73. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets. Mol Pharmacol. 1985 Aug; 28(2):163-9.
    View in: PubMed
    Score: 0.016
  74. Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular disease. Ration Drug Ther. 1985 Jul; 19(7):1-7.
    View in: PubMed
    Score: 0.016
  75. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther. 1985 May; 233(2):418-24.
    View in: PubMed
    Score: 0.016
  76. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia. J Cardiovasc Pharmacol. 1985 Jan-Feb; 7(1):114-20.
    View in: PubMed
    Score: 0.016
  77. Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane. Agents Actions Suppl. 1995; 45:53-8.
    View in: PubMed
    Score: 0.008
  78. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone. Circ Res. 1990 Dec; 67(6):1562-9.
    View in: PubMed
    Score: 0.006
  79. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes. Eicosanoids. 1988; 1(1):41-4.
    View in: PubMed
    Score: 0.005
  80. A novel approach for the study of thromboxane A2 and prostaglandin H2 receptors using an 125I-labeled ligand. Biochem Pharmacol. 1985 Apr 15; 34(8):1165-70.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.